John has extensive product launch experience across multiple therapeutic categories including CNS, ADHD, endocrine, gastrointestinal, cardiovascular, hematology, immunology, and other genetic diseases. The therapeutics John has had responsibility for launching include small molecules, biologics, injectable, and infused products.
John spent most of his career at Shire Pharmaceuticals where was the Head of Global Market Access and Head of Market Access and US Pricing.
Most recently, John was the Chief Commercial Officer at Corium.